These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 8390343

  • 1. Flow cytometric DNA content and clinical outcome in patients with non-small cell lung cancer given postoperative radiation therapy.
    Yu J, Shaeffer J, Zhu A, Kuban DA, el-Mahdi AM, Philput CB.
    Cytometry; 1993; 14(4):428-32. PubMed ID: 8390343
    [Abstract] [Full Text] [Related]

  • 2. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
    Isobe H.
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524
    [Abstract] [Full Text] [Related]

  • 3. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
    Yamaoka N, Uchiyama Y, Kimino K, Akamine S, Matsuo S, Tsuji K.
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1608-16. PubMed ID: 2175839
    [Abstract] [Full Text] [Related]

  • 4. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].
    Liewald F, Sunder-Plassmann L, Valet G, Wulf G, Weiss M, Schildberg FW.
    Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O, Halvorsen OJ, Skjaerven R, Stangeland L, Gulsvik A, Laerum OD.
    Anticancer Res; 1993 Oct; 13(3):571-8. PubMed ID: 8391242
    [Abstract] [Full Text] [Related]

  • 7. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 8. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H, Gumus A, Ozbilim G, Sarper A, Kucukosmanoglu I, Ozbudak IH, Artac M, Ozdogan M, Samur M, Kaya A, Savas B.
    Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
    [Abstract] [Full Text] [Related]

  • 11. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
    Ross P, Grecula J, Bekaii-Saab T, Villalona-Calero M, Otterson G, Magro C.
    Lasers Surg Med; 2006 Dec; 38(10):881-9. PubMed ID: 17115382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 14. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
    Bischof M, Debus J, Herfarth K, Muley T, Kappes J, Storz K, Hoffmann H.
    Strahlenther Onkol; 2007 Dec 21; 183(12):679-84. PubMed ID: 18040612
    [Abstract] [Full Text] [Related]

  • 15. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ.
    Clin Cancer Res; 1997 Jan 21; 3(1):87-93. PubMed ID: 9815542
    [Abstract] [Full Text] [Related]

  • 16. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.
    Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470
    [Abstract] [Full Text] [Related]

  • 17. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR.
    Ann Thorac Surg; 2006 Jun 01; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [Abstract] [Full Text] [Related]

  • 18. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan 01; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.